Diphosphonates

tumor necrosis factor ; Homo sapiens







12 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32530102 Bone mineral density improves during 2 years of treatment with bisphosphonates in patients with ankylosing spondylitis. 2021 Feb 2
2 28725947 Clinical heterogeneity of SAPHO syndrome: challenging diagnose and treatment. 2017 Sep 1
3 26856585 Impaired bone remodeling in children with osteogenesis imperfecta treated and untreated with bisphosphonates: the role of DKK1, RANKL, and TNF-α. 2016 Jul 1
4 24067888 Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 2014 Jan 1
5 24400722 Osteonecrosis of the jaw in a Crohn's disease patient following a course of Bisphosphonate and Adalimumab therapy: a case report. 2014 Jan 8 1
6 23275389 The paradoxical effects of TNF inhibitors on bone mineral density and radiographic progression in patients with ankylosing spondylitis. 2013 Apr 1
7 21441060 Chronic recurrent multifocal osteomyelitis. 2011 Dec 1
8 19692118 Biofunctional alendronate-Hydroxyapatite thin films deposited by Matrix Assisted Pulsed Laser Evaporation. 2009 Oct 1
9 16142752 Tumor necrosis factor prevents alendronate-induced osteoclast apoptosis in vivo by stimulating Bcl-xL expression through Ets-2. 2005 Sep 2
10 15274277 The combination of pamidronate and calcitriol reverses particle- and TNF-alpha-induced altered functions of bone-marrow-derived stromal cells with osteoblastic phenotype. 2004 Jul 1
11 10413987 [TNF-alpha secretion by human macrophage-like cells in response to wear particles and its modification by drugs]. 1999 May 1
12 9351880 An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates. 1997 Nov 1